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Endovascular grafting of abdominal aortic
aneurysms has become increasingly used over the last
years.1-3 When successful, it leads to exclusion of the
aneurysm sac. Unlike conventional open repair, it
does not enable control of side branches. We have
previously shown that successful exclusion leads to a
drop in pressure within the aneurysm sac.4 However,
we have been concerned about a number of our
patients showing perfusion of the aneurysm through
collateral vessels on follow-up and the effect that this
might have on aneurysm growth. Other authors have
also raised concerns about this complication, but
have given no conclusive answer.2,5,6 The mixing of
patients with perfusion through collateral vessels and
patients who have had endoleaks5,6 from the proxi-
mal or distal stentgraft anastomoses, midgraft leaks,
or a leak at the site of the occluder in the contralat-
eral common iliac artery have also clouded results.
We now believe these are two separate groups with
the latter mainly a result of initial technical mishaps
or the remodeling process of the aneurysm during
follow-up and the former caused by naturally existing
vessels. The aim of this study was to see what effect,
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if any, persistent perfusion of the aneurysm sac
through collateral vessels had on the continued
growth of the aneurysm.
MATERIALS AND METHODS
From November 1993 through August 1997, we
treated 81 patients (nine women and 72 men) with
endovascular grafting of a true AAA. This study
excluded seven patients who showed signs of persistent
endoleak during follow-up and seven more patients
subjected to immediate operative conversion. We
excluded three additional patients who went to anoth-
er hospital for follow-up because it did not allow for
adequate analysis and did not adhere completely to fol-
low-up protocol. Thus, we included only patients that
showed no signs of persistent endoleak (n = 64) so this
would not be a factor in further aneurysm develop-
ment. In three patients, we successfully embolized
endoleaks at early postoperative follow-up and detect-
ed collateral perfusion following the embolization.
The study included these patients at the time of collat-
eral perfusion detection, but used only the interval
after the closure of the initial endoleak. All patients
received either aorto-uniiliacal (Ivancev-Malmö sys-
tem7) or bifurcated (Chuter8 or Vanguard9) endograft
systems. We used contrast medium enhanced spiral
computed tomography with 5-mm collimation, 5-mm
table movement and 3-mm reconstructed axial slices,
along with multiplanar (MPR) and three-dimensional
reconstruction for preoperative evaluation in all
patients. One-month and one-year follow-ups used
intraarterial contrast injections. We always used a set of
pre-contrast scans to rule out calcification or throm-
bus, which one can mistake for collateral perfusion. We
also performed arteriograms with a calibrated catheter
to evaluate aneurysm morphology. Follow-up consist-
ed of spiral computed tomography at one, three, six
and 12 months, and biannually thereafter. We per-
formed angiograms postoperatively at one month and
after that when deemed clinically necessary.
Fig. 1c. To find the origin of the perfusion, an angiogra-
phy was performed showing perfusion through a iliolum-
bar artery.
Fig. 1a. A preoperative spiral computer tomography axial
scan of AAA with very little amount of thrombus in the
aneurysm sac.
Fig. 1b. Postoperative spiral computed tomography in
the same patient showing small amount of contrast accu-
mulation in the sac secondary to collateral perfusion. The
contrast was seen only on two axial 3-mm slices.
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We measured maximum AAA diameter at the
widest part of the aneurysm. To avoid miscalcula-
tions as a result of tortuosity, we measured the short-
est diagonal (D), thereby avoiding overestimation of
aneurysm size on slices where the aneurysm
appeared oval. At this same level, we also measured
the corresponding diameter of the aortic thrombus-
free lumen (L) and calculated the quotient L/D to
estimate the amount of thrombus in the aneurysm
sac (Fig. 1a). Because we lacked appropriate com-
puter software, we did not measure on MPR.
You can see the presence of collateral perfusion
most readily on spiral computed tomography scans;
however, we performed an angiogram (including
selective catheterization of hypogastric arteries)
when we detected collateral perfusion to try to elu-
cidate the origin of the perfusion (Fig. lc).
For the analysis in this study, we excluded a
patient with collateral perfusion when the perfusion
stopped at any time, whether this occurred sponta-
neously or by a radiological intervention. Surgical
conversion or patient death was the reason for exclu-
sion in both groups.
The median (M) follow-up time was 15 months.
Interquartile range (IQR) was 3 to 24 months.
(Totally excluded were M = 12, IQR 3-20 months;
perfused M = 18, IQR 3-24 months.)
This study could show normal distributions only
for the ratio L/D, and, therefore, used unpaired
Student t-test only for analysis of this variable. For
all other variables, this study calculated medians and
IQR and used Wilcoxon’s rank sum test for analysis
of paired data and Mann-Whitney test for unpaired
comparisons. The study gives exact p-values and
considers them significant when p <0.05.
The institutional review board approved this
study, and all patients gave informed consent before
surgical intervention and radiographic studies.
RESULTS
The median maximum AAA diameter preopera-
tively was 54 mm (IQR 47-60 mm.) Sixteen patients
(25%) showed signs of collateral perfusion during fol-
low-up. Table I shows the characteristics of the per-
fusion in the individual cases and course of action, if
any, against it. As noted, a majority of the perfusions
visualized early during follow-up. When this was not
the case, we delayed diagnosis because the patient did
not receive a computed tomography at 1 month
postoperatively (n = 2; patients 1 and 2 in Table I
received treatment early in the series when the pro-
tocol was not yet fully established). We also delayed
diagnosis when the patients initially showed con-
comitant endoleak (n = 3; patient 3 in Table I
showed a perioccluder leak, patient 6 a leak at distal
anastomosis and patient 9 a perioccluder leak). In
these cases the diagnosis of collateral perfusion was
made apparent only after embolization closed the
endoleaks. Most cases of collateral perfusion were
small and visible only on one or two 3-mm axial com-
puted tomography slices (Fig. lb). There was no sta-
tistical difference in the size of the aneurysm preop-
eratively between the group that had collateral perfu-
sion and the one that did not. However, the group of
patients with collateral perfusion did have significant-
ly less thrombus in their aneurysmal sac than the
Table I. Characteristics of patients with collateral perfusion 
Patient Number Type of Perfusion Discovered Course of Action Current Status (follow-up time=months)
1 LA 3 mo N CP (36)
2 LA 2 mo Embo 2 mo-S NP (36)
3 LA 3 mo N CP (30)
4 IMA/LA 2 days Embo 12 mo CP (30)
5 LA 2 days N converted-prox migration
6 LA 12 mo N CP (30)
7 LA 1 mo Sp res 12 mo NP (24)
8 IMA 1 mo Warfarin stopped NP (24)
9 LA 3 mo Embo 6 mo CP (24)
10 LA 1 mo Embo 6 mo-S NP (18)
11 LA 1 mo Embo 6 mo meningitis postop-died
12 IMA 1 mo N CP (12)
13 LA 1 mo N cerebral bleed postop-died
14 LA 1 mo N CP (12)
15 LA 1 mo Sp res 6 mo NP (6)
16 LA 1 mo N CP (3)
LA, lumbar artery; IMA, inferior mesenteric artery; mo, month; Embo, embolization; Sp res, spontaneous resolution; N, none; CP, col-
lateral perfusion; NP, no perfusion; S, successful.
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group without perfusion. (Mean L/D = 0.78
(SD±0.21) for the group with perfusion compared to
mean L/D = 0.61 (SD±0.17) for the group without
perfusion or leaks. p = 0.0021.)
The group of patients without perfusion or
endoleaks (n = 48) showed a statistically significant
decrease in aneurysm size postoperatively (Fig. 2).
The median reduction at 18 months was 8 mm
(IQR 4-16mm). There was no correlation between
the size of the aneurysm preoperatively and the post-
operative decrease in size.
The group of 16 patients with no signs of collat-
eral perfusion showed no statistically significant
cumulative increase or decrease in AAA diameter
postoperatively at the different follow-up intervals
(Figs. 3 and 4). However, the median change in aor-
tic diameter at 18 months was a 3-mm decrease
(IQR +3 to -6 mm). Currently, eight patients con-
tinue to have collateral perfusion.
Comparisons of the aortic diameters postopera-
tively between the group with collateral perfusion
and the group with totally excluded AAA failed to
show any statistically significant difference in the
reduction of aneurysm size. At 18-months follow-
up, the aneurysms in the group without perfusion
had decreased an average 7.5 mm more than the
group with perfusion (p = 0.06).
The two patients successfully treated with coil
embolization (patients 2 and 10 in Table I) after the
procedures showed a decrease in AAA diameter of 6
mm and 4 mm, respectively (see Table II).
DISCUSSION
Since the practice of endovascular stentgrafting
(EVG) of abdominal aortic aneurysms started in the
Table II. Change in aortic diameter after collateral
perfusion stopped
Follow-up time (mo) AAA compared 






Patient numbers correspond to numbers in Table I. Patient 15
has not yet been to follow-up after perfusion ceased, and there-
fore, measurement of aortic diameter is not available.
Fig. 2. Change ( D ) in maximum AAA diameter in patients with totally excluded AAA.
Median, 10th, 25th, 75th and 90th percentiles shown. p-values above each box plot refer to
cumulative changes.
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Fig. 4. Aortic aneurysm diameter at follow-up (FU) in patients with collateral perfusion. Only
intervals with ongoing perfusion are shown.
Fig. 3. Change (D ) in maximum AAA diameter in patients with collateral perfusion of AAA.
Median, 10th, 25th, 75th and 90th percentiles shown. p-values above each box plot refer to
cumulative changes.
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beginning of the 1990s, several centers around the
world have adopted the technique. Most investiga-
tors have shown that EVG is a feasible procedure in
a selected group of patients with good short-term
results.9-l1 However, many questions concerning
long-term follow-up are still unanswered. One unan-
swered question, which has raised concern among
several authors, is that some patients show signs of
endoleaks during follow-up. This is noted as contrast
medium accumulation in the aneurysm sac on a spi-
ral computed tomography scan, which probably is
the most sensitive modality for detecting endoleaks.
Resnikoff et al.12 stated that in patients operatively
excluded for AAA with an aorta-iliac extra-anasto-
motic bypass and closure of the aneurysm sac, those
with continuous perfusion of the aneurysm sac, with
no reduction of the size of the sac postoperatively or
continued wall pulsations, were at high risk for sub-
sequent rupture. However, this was only 2% of the
831 analyzed patients. They also raise the concern
that perigraft leaks after endovascular procedures
may become the rate-limiting factor in the further
development of this novel technique. In this context,
we believe it is important to separate the phenome-
non of perfusion through collateral vessels from
endoleaks11 (proximal, midgraft, distal or periocclud-
er) that occur as a result of technical failure of EVG.
When studying the effect these two groups have on
aneurysm expansion, mixing them makes it difficult
to interpret the results. As we have shown in this
analysis, we have not seen any continued dilatation of
the aneurysm sac in patients with collateral perfusion.
On the other hand, we have seen expansion in
patients with endoleaks or where the proximal stent
has migrated distally and left the aneurysm nonex-
cluded (unpublished data).
Another problem that deserves attention is the
fact that the presence of collateral perfusion may be
hard to demonstrate. For the presence of collateral
perfusion, there must be both an inflow and an out-
flow from the aneurysm sac. Theoretically, one can
speculate that even though the AAA seems to be
totally excluded with no signs of contrast medium
accumulation in the aneurysm sac, this may be
caused by the fact that the timing of the CT scan is
incorrect. A scan taken too early in relation to a slow
perfusion flow might result in a negative finding.
Delivery of a dense contrast medium directly into
the aorta during spiral computed tomography (an
intraarterial spiral computed tomography), which we
performed at one-month and one-year follow-ups,
may have contributed to the high rate of detection
of collateral perfusion in our patients. In our follow-
up protocol, we scan all our patients with spiral com-
puted tomography scans with only 3-mm slice thick-
ness. Many collateral perfusions are seen only on one
or two slices and thus easily missed if follow-up uses
thicker slices. We examine the scans very carefully,
specifically searching for endoleaks or collateral per-
fusion. This might be an additional explanation to
why we seem to have significantly more cases of col-
lateral perfusion than other authors have report-
ed.1,13 Even so, small leaks can remain undiscovered
and could explain some cases of seemingly well-
excluded aneurysms that do not show a reduction in
size on follow-up.14 The angiograms at one-month
follow-ups are not as good as spiral computed
tomography for detecting small perfusions. We use
the angiograms mainly as a baseline study for detect-
ing a possible stent migration later in follow-up. The
intra-operative angiograms made with a C-arm are
not of the same quality as those made in a full
angiography suite.
Another aspect of collateral perfusion postopera-
tively is to what additional procedures it should lead.
We have presented previously the option of coil
embolization of collateral vessels as a treatment.15
Others recommend occlusion of major aortic side
branches before EVG as a preventive measure.7,16 In
light of our results, there seems to be a need for stud-
ies in this area. One must keep in mind that no treat-
ment is without risk. In one of the patients described
in this study, we performed multiple coil emboliza-
tions in the same session. The patient suffered from
transient paraplegia, probably due to the excessive
embolization. Others2,17 have chosen to just observe
patients with collateral perfusion and have seen no
aneurysm expansion, an approach congruent with the
findings in this study. Our current criterion for treat-
ing a patient with collateral perfusion is aneurysmal
enlargement of 5 mm or more compared with the pre-
operative measurement. We chose this limit because
the errors of measurement for the individual patient
are approximately 2 to 3 mm (unpublished data).
In this study, we found 16 patients with spiral
computed tomography verified collateral perfusion
that show no statistically significant increases in
aneurysm size on an average follow-up of 18 months.
We subjected five cases to coil embolization, but only
two were successful. The latter two showed a decrease
in AAA diameter after the intervention (6 and 4 mm,
respectively). Two patients out of the 16 with collat-
eral perfusion showed an increase in aneurysm diam-
eter that led to an adjunctive procedure. One had
concomitant graft separation as a plausible explana-
tion for the progressive enlargement, which left only
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one case of “true” expansion with collateral perfusion
as the only reasonable explanation. This was one of
the successful embolization cases. In addition, two
patients had small cumulative increases in AAA diam-
eter at 18 months (2 and 3 mm, respectively), but we
believe these are within measurement error because
they do not seem to be progressive when looking at
previous follow-ups. The group of patients with total
aneurysm exclusion showed a statistically significant
decrease in AAA diameter on follow-up, a finding that
has been shown previously.5,6,18 However, we could
not show any significant difference in postoperative
decrease of AAA diameters between well-excluded
aneurysms and those with collateral perfusion, possi-
bly because the group of patients with collateral per-
fusion was small on later follow-up. Out of the 16
patients with collateral perfusion, only eight patients
currently continue to have perfusion and are under
close observation. We find it interesting that the
patients who showed collateral perfusion on follow-
up had significantly less thrombus in their aneurysm
sac preoperatively as measured by the L/D ratio.
However, a broad overlap between the groups makes
preoperative discrimination difficult. This could sug-
gest that patients with much thrombus have sealed off
their lumbar vessels in contrast to those with less
thrombus, where the collateral vessels are left patent
with a chance of collateral perfusion to the aneurysm
sac occurring.19 The combined finding of little
thrombus in the aneurysm sac and the inability to
seal off collateral vessels implies clotting of the blood
may be in some way disturbed. This theory is consis-
tent with the finding in one of the patients who had
collateral perfusion (patient 8, Table I), which ceased
after warfarin treatment stopped. Our findings do
not support an aggressive policy of coil embolization
of tributaries before EVG, even if the AAA sac con-
tains only a small amount of thrombus and, there-
fore, has a greater chance of collateral perfusion post-
operatively.
In conclusion, this study shows no significant
increase in AAA diameter on an average 18 months
postoperatively, despite persistent collateral perfu-
sion. Even though totally excluded AAA decrease in
size postoperatively, the fact that AAA with collater-
al perfusion do not change in diameter may indicate
a short-term halted disease progression compared to
natural aneurysm growth.20 The long-term risk of
rupture is currently unknown. Adjunctive proce-
dures to close collateral perfusion are not without
risk, in our experience, and not successful in all cases.
For patients with collateral perfusion and stable AAA
diameter on follow-up, we currently recommend
continued close observation instead of surgical pro-
cedures or intervention.
This study is part of the CATPEG within the EC
Framework programme BIOMED, Contract no. BMH4-
97-2250. Coordinator of the project: Professor Bo
Risberg, Department of Vascular Surgery, Sahlgrenska
University Hospital, Gothenburg, Sweden.
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CORRECTION
Fig. 2 was incorrectly printed in the February 1998 article entitled “Preoperative thromboxane
A2/prostaglandin H2 receptor activity predicts early graft thrombosis” by Thomas E. Brothers et al. (J Vasc
Surg 1998;27:317-28). The correct Fig. 2 and the appropriate legend appear below.
Fig. 2. Scatchard analysis of equilibrium binding data for [125I]-BOP from platelets derived
before operation. Nonlinear analysis (LIGAND program) of individual data from patients with
thrombosed grafts (open squares) yielded an average dissociation constant (Kd) of 8.8 nmol/L
and a receptor number (Bmax) of 3100 sites/platelet, and analysis of patients with patent grafts
(filled circles) yielded a Kd of 7.9 nmol/L and a receptor number (Bmax) of 1500 sites/platelet.
Individual patient data have been grouped according to either occluded or patent graft status
for each concentration of unlabeled ligand in this figure for ease of illustration.
